EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Undifferentiated Human Amniotic Fluid Progenitor Cells Promote Bone Regeneration in Vivo

Queralt Vallmajo-Martin iD, Anna-Sofia Kiveliö iD, Stéphanie Metzger iD, Vincent Milleret, Philipp S Lienemann iD, Bianca M Carrara, Christopher Millan, Chafik Ghayor iD, Nicole Ochsenbein-Koelble iD, Martin Ehrbar iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202300843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Queralt Vallmajo-Martin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, University Hospital Zürich (USZ), Zürich, 8091, Switzerland. Hauptthemen laut MEDLINE: Amniotic Fluid, Bone Regeneration, Stem Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Community's Seventh Framework Programme of the Marie Curie INT Project Multiterm, Center for Clinical Research, University Hospital Zürich, and University of Zürich, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of large bone defects requires bone tissue substitutes. However, the lack of accessible autologous bone, especially in newborns with spina bifida or cleft palate conditions, severely limits therapeutic options involving bone grafts. Here, an engineering approach to reconstruct bone is presented by combining human amniocentesis‐derived amniotic fluid progenitor cells (hAFCs) and a biomimetic, injectable, and fully synthetic poly(ethylene glycol) hydrogel that is crosslinked enzymatically by transglutaminase FXIII (TG‐PEG). hAFCs are isolated by their colony‐forming capacity, expanded in vitro, and undergo osteogenic, chondrogenic, or adipogenic differentiation under appropriate stimulation. When encapsulated in TG‐PEG hydrogels, hAFCs rapidly deposit endogenous extracellular matrix (ECM) in vitro. hAFC‐laden TG‐PEG hydrogels containing low concentrations of bone morphogenetic protein (BMP‐2) promote formation of ectopic bone organoids in vivo in a murine model without requiring prior in vitro differentiation. Strikingly, hAFC‐induced constructs form as much bone in this model as adult bone marrow‐derived stromal cells (hBMSCs), and significantly more than adipose‐derived stromal cells (hASCs). Utilization of autologous hAFCs embedded in TG‐PEG hydrogels presents a promising therapeutic strategy for bone replacement, particularly in fetuses and newborns where limited stem cell availability can be overcome through minimally invasive harvest of amniotic fluid.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amniotic FluidBone RegenerationStem CellsHumansAnimalsCell DifferentiationHydrogelsMiceOsteogenesisPolyethylene GlycolsFemaleTissue EngineeringBone Morphogenetic Protein 2

Stichwörter der Autor:innen

amniotic fluid cellsbone regenerationfetal tissue engineeringhydrogelspoly(ethylene glycol)

Substanzen

HydrogelsPolyethylene GlycolsBone Morphogenetic Protein 2

Autor:innen und Institutionen

  • Department of Obstetrics, University Hospital Zürich (USZ), Zürich, 8091, Switzerland.
  • Institute of Bioengineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, 1015, Switzerland.
  • Department of Urology, University Hospital Zürich (USZ), Zürich, 8091, Switzerland.
  • Center of Dental Medicine, Oral Biotechnology & Bioengineering, University of Zürich (UZH), Zürich, 8006, Switzerland.

ORCID-Profile: Queralt Vallmajo-Martin, Anna-Sofia Kiveliö, Stéphanie Metzger, Philipp S Lienemann, Chafik Ghayor, Nicole Ochsenbein-Koelble, Martin Ehrbar

Förderung

  • European Community's Seventh Framework Programme of the Marie Curie INT Project Multiterm
  • Center for Clinical Research, University Hospital Zürich, and University of Zürich
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Novartis Foundation for Medical-Biological Research

Zitieren

APA

Vallmajo-Martin, Q., Kiveliö, A. S., Metzger, S., Milleret, V., Lienemann, P. S., Carrara, B. M., Millan, C., Ghayor, C., Ochsenbein-Koelble, N., & Ehrbar, M. (2025). Undifferentiated Human Amniotic Fluid Progenitor Cells Promote Bone Regeneration in Vivo. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300843

Vancouver

Vallmajo-Martin Q, Kiveliö AS, Metzger S, Milleret V, Lienemann PS, Carrara BM, et al. Undifferentiated Human Amniotic Fluid Progenitor Cells Promote Bone Regeneration in Vivo. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202300843

BibTeX
@article{VallmajoMartin2025,
  author = {Vallmajo-Martin, Queralt and Kiveliö, Anna-Sofia and Metzger, Stéphanie and Milleret, Vincent and Lienemann, Philipp S and Carrara, Bianca M and Millan, Christopher and Ghayor, Chafik and Ochsenbein-Koelble, Nicole and Ehrbar, Martin},
  title = {Undifferentiated Human Amniotic Fluid Progenitor Cells Promote Bone Regeneration in Vivo},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202300843}
}
Kostenlos starten →